Corrigendum to “Apremilast prevent doxorubicin-induced apoptosis and inflammation in heart through inhibition of oxidative stress mediated activation of NF-κB signaling pathways” (Pharmacological Reports (2018) 70(5) (993–1000), (S1734114017306679), (10.1016/j.pharep.2018.03.009))

Faisal Imam; Naif O. Al-Harbi; Mohammad Matar Al-Harbi; Mushtaq Ahmad Ansari; Abdullah F. Al-Asmari; Mohd Nazam Ansari; Wael A. Al-Anazi; Saleh Bahashwan; Mashal M. Almutairi; Musaad Alshammari; Mohammad Rashid Khan; Abdulaziz Mohammed Alsaad; Moureq Rashed Alotaibi

doi:10.1016/j.pharep.2019.06.009

Corrigendum to “Apremilast prevent doxorubicin-induced apoptosis and inflammation in heart through inhibition of oxidative stress mediated activation of NF-κB signaling pathways” (Pharmacological Reports (2018) 70(5) (993–1000), (S1734114017306679), (10.1016/j.pharep.2018.03.009))

Faisal Imam, Naif O. Al-Harbi, Mohammad Matar Al-Harbi, Mushtaq Ahmad Ansari, Abdullah F. Al-Asmari, Mohd Nazam Ansari, Wael A. Al-Anazi, Saleh Bahashwan, Mashal M. Almutairi, Musaad Alshammari, Mohammad Rashid Khan, Abdulaziz Mohammed Alsaad, Moureq Rashed Alotaibi

Pharmacology

Research output: Contribution to journal › Comment/debate

Abstract

The authors regret that the original paper listed an incorrect affiliation for the author Mohd Nazam Ansari. The correct affiliation is presented above. The authors would like to apologize for any inconvenience caused.

Original language	English
Pages (from-to)	1227
Number of pages	1
Journal	Pharmacological Reports
Volume	71
Issue number	6
DOIs	https://doi.org/10.1016/j.pharep.2019.06.009
State	Published - Dec 2019

Access to Document

10.1016/j.pharep.2019.06.009

Fingerprint

Dive into the research topics of 'Corrigendum to “Apremilast prevent doxorubicin-induced apoptosis and inflammation in heart through inhibition of oxidative stress mediated activation of NF-κB signaling pathways” (Pharmacological Reports (2018) 70(5) (993–1000), (S1734114017306679), (10.1016/j.pharep.2018.03.009))'. Together they form a unique fingerprint.

Cite this

Imam, F., Al-Harbi, N. O., Al-Harbi, M. M., Ansari, M. A., Al-Asmari, A. F., Ansari, M. N., Al-Anazi, W. A., Bahashwan, S., Almutairi, M. M., Alshammari, M., Khan, M. R., Alsaad, A. M., & Alotaibi, M. R. (2019). Corrigendum to “Apremilast prevent doxorubicin-induced apoptosis and inflammation in heart through inhibition of oxidative stress mediated activation of NF-κB signaling pathways” (Pharmacological Reports (2018) 70(5) (993–1000), (S1734114017306679), (10.1016/j.pharep.2018.03.009)). Pharmacological Reports, 71(6), 1227. https://doi.org/10.1016/j.pharep.2019.06.009

Imam, Faisal ; Al-Harbi, Naif O. ; Al-Harbi, Mohammad Matar et al. / Corrigendum to “Apremilast prevent doxorubicin-induced apoptosis and inflammation in heart through inhibition of oxidative stress mediated activation of NF-κB signaling pathways” (Pharmacological Reports (2018) 70(5) (993–1000), (S1734114017306679), (10.1016/j.pharep.2018.03.009)). In: Pharmacological Reports. 2019 ; Vol. 71, No. 6. pp. 1227.

@article{9f422832f8304ed1be3a3e2fac1dae05,

title = "Corrigendum to “Apremilast prevent doxorubicin-induced apoptosis and inflammation in heart through inhibition of oxidative stress mediated activation of NF-κB signaling pathways” (Pharmacological Reports (2018) 70(5) (993–1000), (S1734114017306679), (10.1016/j.pharep.2018.03.009))",

abstract = "The authors regret that the original paper listed an incorrect affiliation for the author Mohd Nazam Ansari. The correct affiliation is presented above. The authors would like to apologize for any inconvenience caused.",

author = "Faisal Imam and Al-Harbi, \{Naif O.\} and Al-Harbi, \{Mohammad Matar\} and Ansari, \{Mushtaq Ahmad\} and Al-Asmari, \{Abdullah F.\} and Ansari, \{Mohd Nazam\} and Al-Anazi, \{Wael A.\} and Saleh Bahashwan and Almutairi, \{Mashal M.\} and Musaad Alshammari and Khan, \{Mohammad Rashid\} and Alsaad, \{Abdulaziz Mohammed\} and Alotaibi, \{Moureq Rashed\}",

note = "Publisher Copyright: {\textcopyright} 2018 Institute of Pharmacology, Polish Academy of Sciences",

year = "2019",

month = dec,

doi = "10.1016/j.pharep.2019.06.009",

language = "English",

volume = "71",

pages = "1227",

journal = "Pharmacological Reports",

issn = "2299-5684",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "6",

}

Imam, F, Al-Harbi, NO, Al-Harbi, MM, Ansari, MA, Al-Asmari, AF, Ansari, MN, Al-Anazi, WA, Bahashwan, S, Almutairi, MM, Alshammari, M, Khan, MR, Alsaad, AM & Alotaibi, MR 2019, 'Corrigendum to “Apremilast prevent doxorubicin-induced apoptosis and inflammation in heart through inhibition of oxidative stress mediated activation of NF-κB signaling pathways” (Pharmacological Reports (2018) 70(5) (993–1000), (S1734114017306679), (10.1016/j.pharep.2018.03.009))', Pharmacological Reports, vol. 71, no. 6, pp. 1227. https://doi.org/10.1016/j.pharep.2019.06.009

Corrigendum to “Apremilast prevent doxorubicin-induced apoptosis and inflammation in heart through inhibition of oxidative stress mediated activation of NF-κB signaling pathways” (Pharmacological Reports (2018) 70(5) (993–1000), (S1734114017306679), (10.1016/j.pharep.2018.03.009)). / Imam, Faisal; Al-Harbi, Naif O.; Al-Harbi, Mohammad Matar et al.
In: Pharmacological Reports, Vol. 71, No. 6, 12.2019, p. 1227.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Corrigendum to “Apremilast prevent doxorubicin-induced apoptosis and inflammation in heart through inhibition of oxidative stress mediated activation of NF-κB signaling pathways” (Pharmacological Reports (2018) 70(5) (993–1000), (S1734114017306679), (10.1016/j.pharep.2018.03.009))

AU - Imam, Faisal

AU - Al-Harbi, Naif O.

AU - Al-Harbi, Mohammad Matar

AU - Ansari, Mushtaq Ahmad

AU - Al-Asmari, Abdullah F.

AU - Ansari, Mohd Nazam

AU - Al-Anazi, Wael A.

AU - Bahashwan, Saleh

AU - Almutairi, Mashal M.

AU - Alshammari, Musaad

AU - Khan, Mohammad Rashid

AU - Alsaad, Abdulaziz Mohammed

AU - Alotaibi, Moureq Rashed

PY - 2019/12

Y1 - 2019/12

N2 - The authors regret that the original paper listed an incorrect affiliation for the author Mohd Nazam Ansari. The correct affiliation is presented above. The authors would like to apologize for any inconvenience caused.

AB - The authors regret that the original paper listed an incorrect affiliation for the author Mohd Nazam Ansari. The correct affiliation is presented above. The authors would like to apologize for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85073990534&partnerID=8YFLogxK

U2 - 10.1016/j.pharep.2019.06.009

DO - 10.1016/j.pharep.2019.06.009

M3 - Comment/debate

C2 - 31669887

AN - SCOPUS:85073990534

SN - 2299-5684

VL - 71

SP - 1227

JO - Pharmacological Reports

JF - Pharmacological Reports

IS - 6

ER -

Imam F, Al-Harbi NO, Al-Harbi MM, Ansari MA, Al-Asmari AF, Ansari MN et al. Corrigendum to “Apremilast prevent doxorubicin-induced apoptosis and inflammation in heart through inhibition of oxidative stress mediated activation of NF-κB signaling pathways” (Pharmacological Reports (2018) 70(5) (993–1000), (S1734114017306679), (10.1016/j.pharep.2018.03.009)). Pharmacological Reports. 2019 Dec;71(6):1227. doi: 10.1016/j.pharep.2019.06.009

Corrigendum to “Apremilast prevent doxorubicin-induced apoptosis and inflammation in heart through inhibition of oxidative stress mediated activation of NF-κB signaling pathways” (Pharmacological Reports (2018) 70(5) (993–1000), (S1734114017306679), (10.1016/j.pharep.2018.03.009))

Abstract

Access to Document

Other files and links

Fingerprint

Cite this